Результаты поиска

...[drug]] which acts as a [[binding selectivity|selective]] [[norepinephrine reuptake inhibitor]] and was under development by [[Eli Lilly and Company|Eli Lilly] ...| title = A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression | journal = Journal of Psyc ...

...id994022">{{cite journal | author = Koe BK | title = Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations {{Monoamine reuptake inhibitors}} ...

...authors=Sansone RA, Sansone LA | title = Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison | journal = Innov Clin Neurosci | volume = 11 ...

...typy]].<ref name="Zakusov2013" /> It is known to act as a [[norepinephrine reuptake inhibitor]], [[antihistamine]], and [[anticholinergic]].<ref name="pmid4153 {{Monoamine reuptake inhibitors}} ...

...orepinephrine reuptake inhibitor]], and to a lesser extent as a [[dopamine reuptake inhibitor]].<ref name="pmid96461"/><ref name="pmid106428">{{cite journal | ...Kopajtic TA, Kuhar MJ | title = Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter | journal = Journal ...

..., Lippa AS | title = Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor | journal = European Journal of Pharmacology | volume = 461 | iss ...="pmid12586204"/> The [[IC50|IC₅₀]] values for [[serotonin]], [[norepinephrine]] and [[dopamine]] uptake are 12, 23 and 96 nM, respectively ...

'''HP-505''' is a [[triple reuptake inhibitor]] that was investigated by [[Hoechst-Marion-Roussel|Hoechst-Rouss ! [[Serotonin transporter|5-HT]] !! [[Norepinephrine transporter|NE]] !! [[Dopamine transporter|DA]] !! NE:5-HT !! DA:5-HT ...

...ylphenyl ketone''' is a [[Dopamine reuptake inhibitor|dopamine transporter reuptake inhibitor]] used as a lead compound to find a DRI transporter site antagoni ...K(i) values of 11 and 55 nM in binding affinity and inhibition of dopamine reuptake, respectively). In behavioral pharmacological testing, 6 mimics partially t ...

...'S'')-(±)-diphenyl-2-pyrrolidinyl-methanol, is a [[norepinephrine-dopamine reuptake inhibitor]] which is used as a [[designer drug]].<ref>{{cite journal | vaut {{Monoamine reuptake inhibitors}} ...

! !! {{abbrlink|SERT|Serotonin transporter}} !! {{abbrlink|NET|Norepinephrine transporter}} !! {{abbrlink|DAT|Dopamine transporter}} ...antiomer of didesmethylsibutramine is a more potent inhibitor of monoamine reuptake than the (''S'')-enantiomer and possesses significantly stronger anorectic ...

...chemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating sti ...|date=October 2006 |title=A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant ab ...

...journal | vauthors = Marks DM, Pae CU, Patkar AA | title = Triple reuptake inhibitors: a premise and promise | journal = Psychiatry Investigation | volume = 5 | ...aking it a broad-spectrum [[monoamine transporter]] inhibitor or "[[triple reuptake inhibitor]]."<ref name=Basile>{{cite journal | vauthors = Basile AS, Janows ...

...[[dopamine]] by blocking the action of the [[dopamine transporter]] (DAT). Reuptake inhibition is achieved when extracellular dopamine not absorbed by the [[po ...[[controlled substance|legal restriction]]s on their use. Lack of dopamine reuptake and the increase in extracellular levels of dopamine have been linked to in ...

...our knowledge of monoamine oxidase (MAO) help in the design of better MAO inhibitors?|journal=Journal of Neural Transmission. Supplementum|year=1994|volume=41|p [[Category:Monoamine oxidase inhibitors]] ...

...83.164 | s2cid = 42205772 }}</ref> It acts as a [[serotonin-norepinephrine reuptake inhibitor]] (SNRI), with little affinity for the [[muscarinic acetylcholine [[Category:Serotonin–norepinephrine reuptake inhibitors]] ...

'''Cilobamine''' is a drug which acts as a [[norepinephrine-dopamine reuptake inhibitor]] (NDRI) and has [[stimulant]] and [[antidepressant]] effects.<re [[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

...ars to [[reuptake inhibitor|inhibit]] the [[reuptake]] of [[serotonin]], [[norepinephrine]], and [[dopamine]], and may also induce their [[releasing agent|release]] {{Monoamine reuptake inhibitors}} ...

...057371}}</ref> Later, it was discovered to be a highly potent [[dopamine reuptake inhibitor]].<ref name="pmid10721502">{{cite journal|vauthors=Motel WC, Heal ...atively low [[affinity (pharmacology)|affinity]] for the closely related [[norepinephrine transporter]] (NET, K{{sub|i}} = 1107&nbsp;nM ) and the [[serotonin transpo ...

...Inazu M, Yamazaki Y, Oguchi K | title = Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats | journal {{Monoamine reuptake inhibitors}} ...

...), which is an [[active metabolite]] of the marketed [[selective serotonin reuptake inhibitor]] (SSRI) [[antidepressant]] [[sertraline]] (Zoloft). ...11 | status = application | title = Cycloalkylamines as monoamine reuptake inhibitors | pubdate = 2007-08-30 | inventor =Shao L, Wang F, Malcolm SC, Hewitt MC, B ...